Kidney Care Community News

Baxter International Inc. has obtained two emergency use authorizations from the FDA for patients who may develop AKI during the COVID-19 pandemic.

The FDA has accepted a biologics license application and granted priority review to a therapy shown to stabilize kidney function in patients with Fabry disease, according to a press release from Protalix BioTherapeutics.

DaVita Inc. reported positive second-quarter earnings despite the ongoing impact of the COVID-19 pandemic and other financial challenges.

Blue Shield of California has partnered with Cricket Health to develop a “personalized and comprehensive care coordination program” for its members with late-stage chronic kidney disease or end-stage kidney disease.

Changes proposed to the Medicare Physician Fee Schedule for next year include making permanent certain telehealth and workforce flexibilities provided during the COVID-19 pandemic, CMS announced in a press release.

The American Kidney Fund has developed a financial assistance program to ensure that low-income kidney transplant recipients receive adequate testing following transplantation, according to a press release.

Baxter International has expanded its partnership with behavioral science-based digital health company Ayogo Health Inc. to support patients with kidney disease through digital platforms, according to a press release.

Women with elevated serum creatinine levels before pregnancy may have a greater risk for giving birth pre-term, according to a recent study.

U.S. News & World Report has released the 31st edition of its “Best Hospitals” rankings, which includes the best hospitals for nephrology. For 2020 to 2021, the Mayo Clinic again ranked number one.

A study supported by the National Institutes of Health found similar outcomes for patients with HIV who underwent transplantation with an HIV+ or HIV– kidney, suggesting infected and uninfected organs have comparable safety profiles.